Home > Healthcare > Medical Devices > Surgical Devices > Minimally Invasive Surgical Instrument Market

Minimally Invasive Surgical Instrument Market Trends

  • Report ID: GMI7717
  • Published Date: Dec 2023
  • Report Format: PDF

Minimally Invasive Surgical Instrument Market Trends

Surging demand for integrated artificial intelligence (AI) in healthcare and MIS procedures, rise in need for smart technologies into surgical instruments, are among the key variables boosting the technological advancement in industry. Moreover, factors such as growing trend toward the use of disposable and single-use instruments collectively contribute to the evolving landscape of the minimally invasive surgical instrument industry.
 

  • The use of surgical robots in minimally invasive surgeries is becoming more prevalent since last few decades as  it offers improved accuracy, dexterity, and visualisation. Surgeons are more frequently employing robotic platforms for complex surgeries as they are more sophisticated. The trend is outlined by continual advancements in robotic technology, that increases the scope of minimally invasive procedures across multiple specialties.
     
  • Additionally, materials and manufacturing technology advancements have resulted in the development of smaller and more accurate instruments. Miniaturised devices are highly beneficial in microsurgery and other operations that need precise manoeuvring. Miniaturisation increases the adaptability and capability of MIS equipment, enabling for more delicate and specialised treatments.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for minimally invasive surgical instrument was valued at over USD 25.7 billion in 2023 and is estimated to reach around USD 53.3 billion by 2032 attributed to the increasing prevalence of chronic diseases, continual technological advancements, and rise in the volume of surgeries among others.

The handheld instruments segment was valued at around USD 6.1 billion revenue in 2023 and is expected to grow significantly through 2032 owing to continuous advancements in portable device designs.

North America minimally invasive surgical instrument industry accounted for USD 10.2 billion revenue in 2023 and is predicted to witness substantial growth through 2032 due to continuous advancements in robotics, imaging technologies, and rising popularity of smart instruments.

Medtronic Plc, Siemens Healthineer AG, Ethicon, Inc. (Johnson & Johnson), GE Healthcare, Abbott Laboratories, Intutive Surgical, Inc., Nuvasive, Inc., Zimmer Biomet, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, CONMED Corporation, Smith & Nephew Plc., and Becton, Dickinson and Company.

Minimally Invasive Surgical Instrument Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 292
  • Countries covered: 22
  • Pages: 160
 Download Free Sample